- Home
- Publications
- Publication Search
- Publication Details
Title
KPT-330 has antitumour activity against non-small cell lung cancer
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 111, Issue 2, Pages 281-291
Publisher
Springer Nature
Online
2014-06-20
DOI
10.1038/bjc.2014.260
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prognostic impact and targeting of CRM1 in acute myeloid leukemia
- (2013) K. Kojima et al. BLOOD
- KPT-330 inhibitor of CRM1 (XPO1)-mediated nuclear export has selective anti-leukaemic activity in preclinical models of T-cell acute lymphoblastic leukaemia and acute myeloid leukaemia
- (2013) Julia Etchin et al. BRITISH JOURNAL OF HAEMATOLOGY
- Potential effects of CRM1 inhibition in mantle cell lymphoma
- (2013) Ke-Jie Zhang et al. Chinese Journal of Cancer Research
- Selective inhibitors of nuclear export for the treatment of non-Hodgkin's lymphomas
- (2013) A. S. Azmi et al. HAEMATOLOGICA
- Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor–Resistant Disease
- (2013) Kadoaki Ohashi et al. JOURNAL OF CLINICAL ONCOLOGY
- CRM1 inhibition induces tumor cell cytotoxicity and impairs osteoclastogenesis in multiple myeloma: molecular mechanisms and therapeutic implications
- (2013) Y-T Tai et al. LEUKEMIA
- CRM1 and BRAF Inhibition Synergize and Induce Tumor Regression in BRAF-Mutant Melanoma
- (2013) R. A. Salas Fragomeni et al. MOLECULAR CANCER THERAPEUTICS
- Nuclear export inhibition through covalent conjugation and hydrolysis of Leptomycin B by CRM1
- (2013) Qingxiang Sun et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Selective inhibitors of nuclear export show that CRM1/XPO1 is a target in chronic lymphocytic leukemia
- (2012) R. Lapalombella et al. BLOOD
- Preclinical activity of a novel CRM1 inhibitor in acute myeloid leukemia
- (2012) P. Ranganathan et al. BLOOD
- Selective Inhibitors of Nuclear Export Block Pancreatic Cancer Cell Proliferation and Reduce Tumor Growth in Mice
- (2012) Asfar S. Azmi et al. GASTROENTEROLOGY
- Inhibition of CRM1-Mediated Nucleocytoplasmic Transport: Triggering Human Melanoma Cell Apoptosis by Perturbing Multiple Cellular Pathways
- (2012) Gaurav Pathria et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Antileukemic activity of nuclear export inhibitors that spare normal hematopoietic cells
- (2012) J Etchin et al. LEUKEMIA
- Chemotherapeutic Sensitization of Leptomycin B Resistant Lung Cancer Cells by Pretreatment with Doxorubicin
- (2012) Chuanwen Lu et al. PLoS One
- Nuclear export of proteins and drug resistance in cancer
- (2011) Joel G. Turner et al. BIOCHEMICAL PHARMACOLOGY
- p73 tumor suppressor protein: A close relative of p53 not only in structure but also in anti-cancer approach?
- (2011) Joanna Zawacka-Pankau et al. CELL CYCLE
- P73 regulates cisplatin-induced apoptosis in ovarian cancer cells via a calcium/calpain-dependent mechanism
- (2011) S Al-Bahlani et al. ONCOGENE
- Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancer
- (2010) David J. Stewart CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Targeting the p53-Family in Cancer and Chemosensitivity: Triple Threat
- (2010) J. Chung et al. CURRENT DRUG TARGETS
- Human Multiple Myeloma Cells Are Sensitized to Topoisomerase II Inhibitors by CRM1 Inhibition
- (2009) J. G. Turner et al. CANCER RESEARCH
- Identification of Nuclear Export Inhibitors with Potent Anticancer Activity In vivo
- (2009) S. C. Mutka et al. CANCER RESEARCH
- Pifithrin-α protects against DNA damage-induced apoptosis downstream of mitochondria independent of p53
- (2009) D Sohn et al. CELL DEATH AND DIFFERENTIATION
- The p53 Family Protein p73 Provides New Insights into Cancer Chemosensitivity and Targeting
- (2009) P. Lunghi et al. CLINICAL CANCER RESEARCH
- EXPRESSION OF CRM1 IN HUMAN GLIOMAS AND ITS SIGNIFICANCE IN P27 EXPRESSION AND CLINICAL PROGNOSIS
- (2009) Aiguo Shen et al. NEUROSURGERY
- Expression of the nuclear export protein chromosomal region maintenance/exportin 1/Xpo1 is a prognostic factor in human ovarian cancer
- (2008) Aurelia Noske et al. CANCER
- Therapeutic prospects for p73 and p63: Rising from the shadow of p53
- (2008) Anna Vilgelm et al. DRUG RESISTANCE UPDATES
- The Karyopherin proteins, Crm1 and Karyopherin β1, are overexpressed in cervical cancer and are critical for cancer cell survival and proliferation
- (2008) Pauline J. van der Watt et al. INTERNATIONAL JOURNAL OF CANCER
- Combined Effects of p53 Gene Therapy and Leptomycin B in Human Esophageal Squamous Cell Carcinoma
- (2008) Isamu Hoshino et al. ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now